Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2012
03/22/2012WO2012036870A2 Monoclonal antibodies and detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid
03/22/2012WO2012036691A1 Use of female mammal's urine for determination of fetal gender related characteristics
03/22/2012WO2012036675A1 Phosphatase coupled kinase assay
03/22/2012WO2012036622A1 System and method for analyzing risk or presence of organ failure
03/22/2012WO2012036350A1 Method for detecting target mrna of synthesized micro-rna
03/22/2012WO2012036329A1 Composition or kit for making a prognosis of liver cancer, and method for making a prognosis of liver cancer
03/22/2012WO2012036259A1 Model animal for studying hair growth cycle
03/22/2012WO2012036215A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method
03/22/2012WO2012036211A1 Skin activation by means of pdgf-bb activity enhancement
03/22/2012WO2012036094A1 Lung cancer identification marker
03/22/2012WO2012035726A1 Biological sample measurement system
03/22/2012WO2012035705A1 Method for determining effectiveness of medicine containing antibody as component
03/22/2012WO2012035568A2 Electrical or electronic apparatus, in particular welding machine or battery charger
03/22/2012WO2012035518A1 Compositions and methods for treatment of drug resistant multiple myeloma
03/22/2012WO2012035508A2 Method for separating target molecules or particles from fibrinogen-containing samples including blood components
03/22/2012WO2012035462A1 Magnetic system for particle attraction in a plurality of chambers
03/22/2012WO2012035369A1 Method for the diagnosis and/or prognosis of inflammatory states
03/22/2012WO2012035330A2 Vaccines
03/22/2012WO2012035297A1 Analyte measurement method and system with hematocrit compensation
03/22/2012WO2012035296A2 Assay for prions
03/22/2012WO2012035166A1 Method for the diagnosis and/or prognosis of inflammatory states
03/22/2012WO2012035115A1 A raft deficient yeast expression system for the production of recombinant membrane proteins
03/22/2012WO2012035088A1 Na+/Mg2+ exchanger
03/22/2012WO2012035066A1 Hot1 and uses thereof
03/22/2012WO2012034986A1 Method for detecting macromolecular silicon organic compounds and device therefor
03/22/2012WO2012034946A1 Preparation of a molecular recognition element
03/22/2012WO2012034761A1 Method for determining a property of a gas in a measurement gas space
03/22/2012WO2012018857A8 Prediction of and monitoring cancer therapy response based on gene expression profiling
03/22/2012WO2012013617A3 Polymeric complements to b-amyloid peptides
03/22/2012WO2012007903A3 A method of detecting surrogate markers for active tuberculosis in a serum sample
03/22/2012WO2012006556A3 Analyte detection using proximity probes
03/22/2012WO2011161628A3 Method for screening compounds for treatment of tumors bearing activated oncogenes and compounds thereof
03/22/2012WO2011157446A4 Biomarkers for the prediction of incident cancer
03/22/2012WO2011156694A3 Enrichment and purification of infectious prion proteins
03/22/2012WO2011156529A3 Methods and composition for multiplex sequencing
03/22/2012WO2011154640A3 Trmp1, mmp2, mia or ptgs1 modulators in the treatment of melasma
03/22/2012WO2011154639A3 Edn3 and/or ednrb modulators in the treatment of melasma
03/22/2012WO2011149250A3 Tricarbonyl technetium-99m or rhenium-188 label ring rgd derivative, a preparation method thereof, and a pharmaceutical composition containing the derivative as an active ingredient for use in the diagnosis or treatment of angiogenesis-related diseases
03/22/2012WO2011142858A9 Chlorotoxin variants, conjugates, and methods for their use
03/22/2012WO2011129622A3 Microfluidic device
03/22/2012WO2011121447A3 Method and apparatus for analysis of an engineered nanoparticle distribution in a substrate
03/22/2012WO2011112845A3 Methods and compositions related to a multi-methylation assay to predict patient outcome
03/22/2012WO2011085300A3 Compostions and methods relating to monitoring alcohol consumption and alcohol abuse
03/22/2012WO2011083461A3 Method for diagnosing and monitoring schizophrenia and tauopathies
03/22/2012WO2011080408A3 Method and spectroscopic analysis appliance, especially for analysing food, with multi-channel treatment of spectral data
03/22/2012WO1996002235A9 Injectable res avoiding inorganic particles
03/22/2012US20120073003 Apobec3 mediated dna editing
03/22/2012US20120073002 Prevention and treatment of blood coagulation-related disases
03/22/2012US20120073001 Methods and compositions for treating or preventing pruritis
03/22/2012US20120072125 Assay Device
03/22/2012US20120072124 Genes associated with progression and response in chronic myeloid leukemia and uses thereof
03/22/2012US20120072120 Automatic threshold setting and baseline determination for real-time pcr
03/22/2012US20120072119 Methods To Diagnose Treat and Prevent Bone Loss
03/22/2012US20120072118 Variation analysis for multiple templates on a solid support
03/22/2012US20120071738 Methodology and equipment of optical rotation measurements
03/22/2012US20120071728 Method for determining the gastric emptying
03/22/2012US20120071483 Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of cell stress response
03/22/2012US20120071443 Nanoparticles
03/22/2012US20120071436 Method, composition and kit for antigenic binding of norwalk-like viruses
03/22/2012US20120071418 Inhibitors of Human EZH2 and Methods of Use Thereof
03/22/2012US20120071417 Methods of inhibiting cancer cell growth with hdac inhibitors and methods of screening for hdac10 inhibitors
03/22/2012US20120071361 Substrate Preparation Process
03/22/2012US20120071356 Variants in Complement Regulatory Genes Predict Age-Related Macular Degeneration
03/22/2012US20120071347 Compositions and methods for monitoring and detecting cancerous conditions
03/22/2012US20120071340 Biomarkers
03/22/2012US20120071339 Biomarkers
03/22/2012US20120071337 Methods
03/22/2012US20120071335 Method for Identification, Selection and Analysis of Tumour Cells
03/22/2012US20120071334 Methods And Marker Combinations For Screening For Predisposition To Lung Cancer
03/22/2012US20120071327 Indexing of nucleic acid populations
03/22/2012US20120070912 Detection method and quantification method for target substance
03/22/2012US20120070911 Method of Detecting and Quantifying Analytes of Interest in a Liquid and Implementation Device
03/22/2012US20120070909 Label-free method for detecting presence or absence of nucleic acids
03/22/2012US20120070908 Immuno conjugate and process for preparation thereof
03/22/2012US20120070905 Processes and Devices for Determining Body Parameters
03/22/2012US20120070903 Method and apparatus for measuring the hot-spot temperature in an electric apparatus containing an oil
03/22/2012US20120070857 ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES
03/22/2012US20120070855 Method for in vitro assay of soluble fibrin by generating specific degradation products
03/22/2012US20120070854 HNRNP A3 Related Peptides and Use Thereof for Diagnosis of Rheumatoid Arthritis
03/22/2012US20120070853 Ykl-40 as a marker for gastrointestinal cancers
03/22/2012US20120070851 Antibody specific to methicillin resistant staphylococcus aureus, detection method and kit for methicillin resistant staphylococcus aureus using the same
03/22/2012US20120070850 Method for detecting microorganisms and microorganism detecting apparatus
03/22/2012US20120070849 Methods and compositions for risk stratification
03/22/2012US20120070848 Tumor cell-derived microvesicles
03/22/2012US20120070847 Method For Detecting And Purifying Pancreatic Beta Cells
03/22/2012US20120070846 Methods for detecting molecule-molecule interactions with a single detection channel
03/22/2012US20120070845 Methods, systems and reagents for improved immunodetection
03/22/2012US20120070844 Method For Quantifying Modified Peptides
03/22/2012US20120070843 Dbc1, a novel native inhibitor of the anti-aging protein sirt1
03/22/2012US20120070837 CIP2A as a biomarker in detection of cervical cancer
03/22/2012US20120070836 Methods of detecting residual amounts of polymers used in the purification of biomolecules
03/22/2012US20120070833 Lateral flow microfluidic assaying device and related method
03/22/2012US20120070827 Detection of fetal cells from maternal blood
03/22/2012US20120070822 Method for signal amplification during lateral-flow analysis
03/22/2012US20120070821 Interference Control Panel for Evaluation of Analytical Assays For Samples Derived from Blood
03/22/2012US20120070819 Determination of Interactions of Constant Parts of Antibodies with FC-Gamma Receptors
03/22/2012US20120070461 Use of myeloid cell biomarkers for the diagnosis of cancer
03/22/2012US20120070460 Dendritic cell modulatory molecule
03/22/2012US20120070437 Method of identifying compounds that bind baff-r
03/22/2012US20120070430 Identification of tumor-associated markers for diagnosis and therapy
1 ... 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 ... 3937